The SDHC Gene Pheochromocytoma Type 3 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the SDHC gene that are associated with Pheochromocytoma Type 3. Pheochromocytomas are rare, usually benign tumors that arise from the chromaffin cells of the adrenal gland, leading to an overproduction of catecholamines, which can cause hypertension, palpitations, and a host of other symptoms. The Type 3 variant of this condition is specifically linked to mutations in the SDHC gene, part of the mitochondrial complex II, which plays a crucial role in the electron transport chain and energy production within cells.
This genetic test is crucial for individuals with a family history of pheochromocytomas or those who have clinical symptoms suggestive of this condition. Early and accurate detection of SDHC gene mutations can guide treatment decisions, inform surveillance for affected individuals and at-risk family members, and help in the management of the condition to prevent potential complications.
The test is conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities and adherence to international standards in genetic diagnostics. The cost of the SDHC Gene Pheochromocytoma Type 3 Genetic Test is 4400 AED, reflecting the specialized nature of the test and the comprehensive analysis it entails.
The SDHAF2 Gene Pheochromocytoma Type 5 Genetic Test is a specialized diagnostic assessment conducted to identify mutations in the SDHAF2 gene, which are linked to the development of Type 5 Pheochromocytoma, a rare type of tumor that originates from the adrenal glands. These tumors can produce excess hormones leading to high blood pressure, heart palpitations, and other serious symptoms. Early detection through genetic testing can significantly improve management and treatment options for individuals at risk. The test is available at DNA Labs UAE, a reputable facility known for its comprehensive genetic testing services. The cost for this specific test is set at 4400 AED, providing a crucial resource for individuals and families seeking to understand their genetic predisposition to this rare condition.
The TMEM127 Gene Pheochromocytoma Type 8 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the TMEM127 gene, which are linked to the development of Pheochromocytoma Type 8. Pheochromocytomas are rare, usually benign tumors that arise from the adrenal glands and can lead to excessive production of adrenaline, causing high blood pressure, heart palpitations, and other symptoms. The identification of a mutation in the TMEM127 gene can provide crucial information for individuals with a family history of the condition or those presenting symptoms suggestive of pheochromocytoma, facilitating early diagnosis and management. This genetic test is priced at 4400 AED and is conducted with state-of-the-art technology to ensure accurate and reliable results, aiding in the personalized treatment planning and genetic counseling for affected individuals and their families.
The MAX Gene Pheochromocytoma Type 9 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the MAX gene, which are linked to the development of Pheochromocytoma, a rare tumor of the adrenal glands. This condition can lead to excessive production of adrenaline, causing high blood pressure, heart palpitations, and a range of other symptoms. Identifying mutations in the MAX gene is crucial for early diagnosis and management of the condition, as well as for assessing the risk within families. The test is priced at 4400 AED, making it an accessible option for individuals seeking comprehensive genetic analysis in the UAE.
The AIP gene pituitary adenoma ACTH-secreting due to AIP germline mutation genetic test is a specialized diagnostic assessment offered at DNA Labs UAE. This test is specifically designed to identify mutations in the AIP gene, which can lead to the development of pituitary adenomas that secrete adrenocorticotropic hormone (ACTH). These adenomas can result in various clinical manifestations, including Cushing's disease, due to the overproduction of cortisol by the adrenal glands.
The AIP (aryl hydrocarbon receptor-interacting protein) gene plays a crucial role in tumor suppression within the pituitary gland. Mutations in this gene can disrupt its function, increasing the risk of developing pituitary adenomas. Identifying a mutation in the AIP gene can provide essential information for the diagnosis, treatment planning, and management of patients affected by or at risk of developing these tumors.
The test is performed at DNA Labs UAE, a facility known for its advanced genetic testing services. The cost of the test is 4400 AED, reflecting the specialized nature of the assessment and the detailed, personalized insights it offers into a patient's genetic predisposition to developing ACTH-secreting pituitary adenomas. This information can be invaluable for patients and their healthcare providers in devising a comprehensive approach to treatment and monitoring, potentially improving outcomes and quality of life for those affected.
The AIP Gene Pituitary Adenoma Growth Hormone-Secreting Due to AIP Germline Mutation Genetic Test is a specialized diagnostic procedure conducted to identify mutations in the AIP gene, which are linked to the development of pituitary adenomas that secrete excess growth hormone. These adenomas can lead to conditions such as gigantism in children or acromegaly in adults, characterized by abnormal growth and other physiological complications. The test is particularly crucial for individuals with a family history of pituitary tumors or those exhibiting symptoms related to excessive growth hormone production.
Performed at DNA Labs UAE, the test involves analyzing the patient's DNA to detect mutations in the AIP gene, which plays a significant role in tumor suppression in the pituitary gland. Identifying such mutations can not only confirm the diagnosis but also help in assessing the risk for family members, guiding treatment decisions, and monitoring disease progression.
The cost of the AIP Gene Pituitary Adenoma Growth Hormone-Secreting Due to AIP Germline Mutation Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the genetic analysis and comprehensive interpretation of results, providing patients and their healthcare providers with critical information for managing and treating the condition effectively.
The "AIP Gene Pituitary Adenoma Prolactin-Secreting Due to AIP Germline Mutation Genetic Test" is a specialized diagnostic procedure aimed at individuals who may be predisposed to developing prolactin-secreting pituitary adenomas as a result of mutations in the AIP gene. The AIP (Aryl Hydrocarbon Receptor Interacting Protein) gene plays a crucial role in tumor suppression, particularly within the pituitary gland. Mutations in this gene can lead to an increased risk of developing pituitary adenomas, which are benign tumors that can significantly affect hormonal balance and health.
This genetic test, performed by DNA Labs UAE, is designed to detect mutations in the AIP gene, thereby identifying individuals at a higher risk of developing these tumors. Early detection through genetic testing can facilitate timely monitoring and intervention, potentially preventing the development of significant health issues.
The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the profound implications it holds for patients and their families. By identifying a genetic predisposition to prolactin-secreting pituitary adenomas, affected individuals can make informed decisions regarding their health management and surveillance strategies, in consultation with their healthcare providers.
The DICER1 gene pleuropulmonary blastoma genetic test is a specialized diagnostic tool aimed at identifying mutations in the DICER1 gene, which are associated with an increased risk of developing pleuropulmonary blastoma, a rare type of lung cancer that primarily affects children. This genetic test is crucial for early detection and intervention, potentially improving patient outcomes through tailored treatment plans.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test provides a comprehensive analysis of the DICER1 gene to detect any genetic abnormalities that may predispose individuals to pleuropulmonary blastoma and other DICER1-related conditions. With a cost of 4400 AED, the test is an investment in health, particularly for families with a history of related cancers, offering peace of mind through advanced genetic insights.
By opting for this test at DNA Labs UAE, patients and their families can access cutting-edge genetic testing technologies, expert analysis, and personalized advice on managing and mitigating the risks associated with DICER1 gene mutations. This proactive approach to health management empowers individuals with crucial information to make informed decisions about their healthcare and the well-being of their family members.
The JAK2 Gene Polycythemia Vera Somatic Genetic Test is a specialized diagnostic examination aimed at detecting mutations in the JAK2 gene, which are strongly associated with the development of polycythemia vera, a type of blood cancer. This condition is characterized by the excessive production of red blood cells, leading to increased blood viscosity and the risk of thrombosis. The test is crucial for the accurate diagnosis and management of the disease, enabling personalized treatment plans that can significantly improve patient outcomes. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test is priced at 4400 AED. DNA Labs UAE utilizes advanced technology to ensure precise and reliable results, making it a trusted choice for patients and healthcare providers seeking comprehensive insights into genetic conditions like polycythemia vera.
The GREM1 Gene Polyposis Syndrome Hereditary Mixed Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the GREM1 gene. These mutations are associated with hereditary mixed polyposis syndrome (HMPS), a rare condition that increases an individual's risk of developing colorectal cancer due to the formation of multiple polyps in the colon and rectum. This genetic test plays a crucial role in early detection, allowing for timely intervention and management strategies to reduce the risk of cancer development.
Priced at 4400 AED, the test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities in the GREM1 gene. Early diagnosis through this test can significantly impact the treatment and surveillance strategies for individuals and their families, offering a proactive approach to managing the syndrome and its associated risks. DNA Labs UAE provides this advanced genetic testing service as part of its commitment to offering cutting-edge diagnostic solutions for inherited diseases and conditions.
